MSN: UC, UC Health launching clinical trial to study effectiveness of COVID-19 vaccine
Vaccine uses a genetic code to produce proteins that may generate protective antibodies
UC and UC Health are hosting a Phase 3 clinical trial to evaluate the effectiveness of a vaccine for COVID-19. UC is one of 90 sites across the United States selected for the study, which will administer the vaccine to volunteer participants and monitor its efficacy in eliciting an immune response that provides protection from COVID-19. The study is led by Carl Fichtenbaum, MD, and Maggie Powers-Fletcher, PhD, both of the UC College of Medicine Division of Infectious Diseases.
Other coverage:
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
UC joins novel bipolar research and clinical care network
March 12, 2025
The University of Cincinnati is one of four new national institutions to receive $2.3 million each to join the Breakthrough Discoveries for Thriving with Bipolar Disorder (BD²) Integrated Network, a collaborative research and clinical care model with a mission to improve care, interventions and outcomes for people living with bipolar disorder.
REVIEW: CCM's 'A Midsummer Night's Dream' an 'exuberant triumph
March 10, 2025
The Cincinnati Business Courier praises UC College-Conservatory of Music's production of A Midsummer Night's Dream. Presented as part of the Opera Series on March 6-9, the production was directed by Robin Guarino and conducted by alumni guest artist William Langley.
Impact of chronic kidney disease escalates around the world
March 10, 2025
The impact of chronic kidney disease (CKD) keeps escalating around the world, and this burden is projected to rise with population growth and aging, according to a study published in BMC Public Health. “The aging population, rising obesity rates and higher diabetes prevalence suggest that the CKD burden will continue to grow,” said Prakash Gudsoorkar, MD, a University of Cincinnati College of Medicine nephrologist and medical lead for the onconephrology service at UC Health.